Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB02Antihemorrhagics
- Pharmacological subgroupB02B
- Chemical subgroupB02BDBlood coagulation factors
- Chemical substanceB02BD07Coagulation factor xiii
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 7 registrations
- Corifact 12501250 UNIT / VIAL · Powder For Solution · CSL Behring Canada INC
- Corifact 250250 UNIT / VIAL · Powder For Solution · CSL Behring Canada INC
- Tisseel Kit VH50 MG / PCK + 3000000 UNIT / PCK + 40 MMOL / PCK + 50 UNIT / PCK + 110 MG / PCK + 9 MG / PCK + 120 MCG / PCK + 4 UNIT / PCK + 500 UNIT / PCK · Jelly · Osterreichisches Institut Fur Haemoderivate Ges M.B.H.
- Tisseel Kit VH 0.50.5 ML / VIAL + 0.5 ML / VIAL + 25 UNIT / VIAL + 55 MG / VIAL + 4.5 MG / VIAL + 60 MCG / VIAL + 250 UNIT / VIAL + 2 UNIT / VIAL + 65 MG / VIAL · Kit, Liquid, Powder For Solution · Baxter AG
Netherlands
CBG-MEB · 5 registrations
At a glance
- ATC code
- B02BD07
- ATC group
- Blood and blood-forming organs
- Registers
- 3
- Registrations
- 14
- With their own page
- 8
- Companies
- 6
All medicines with Coagulation factor xiii
Human medicines from every register that match Coagulation factor xiii by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
15 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tretten | United States | 2000 - 3125IU | For Injection | Marketed | Novo Nordisk Inc. |
| Cluvot 250 Ui, Polvo y Disolvente Para Solucion Inyectable O Perfusion | Spain | 200-300 UI | polvo y disolvente para solución inyectable y para perfusión | Marketed | Csl Behring Gmbh |
| Corifact 250 | Canada | 250 UNIT / VIAL | Powder For Solution | Marketed | CSL Behring Canada INC |
| Corifact 1250 | Canada | 1250 UNIT / VIAL | Powder For Solution | Marketed | CSL Behring Canada INC |
| Cluvot 250 IE, poeder en oplosmiddel voor oplossing voor injectie of infusie | Netherlands | Poeder en oplosmiddel voor oplossing voor infusie, Poeder en oplosmiddel voor oplossing voor injectie | Authorised | CSL Behring GmbH | |
| Cluvot 1250 IE, poeder en oplosmiddel voor oplossing voor injectie of infusie | Netherlands | Poeder en oplosmiddel voor oplossing voor infusie, Poeder en oplosmiddel voor oplossing voor injectie | Authorised | CSL Behring GmbH | |
| Tisseel 10 MLCombination | Netherlands | Weefsellijm | Authorised | Baxter B.V. | |
| Tisseel 2 MLCombination | Netherlands | Weefsellijm | Authorised | Baxter B.V. | |
| Tisseel 4 MLCombination | Netherlands | Weefsellijm | Authorised | Baxter B.V. | |
| Cluvot 1250 Ui, Polvo y Disolvente Para Solucion Inyectable O Perfusion | Spain | 1000-1600 UI | polvo y disolvente para solución inyectable | Withdrawn | Csl Behring Gmbh |
| Tisseel Kit VHCombination | Canada | 50 MG / PCK + 3000000 UNIT / PCK + 40 MMOL / PCK + 50 UNIT / PCK + 110 MG / PCK + 9 MG / PCK + 120 MCG / PCK + 4 UNIT / PCK + 500 UNIT / PCK | Jelly | Cancelled | Osterreichisches Institut Fur Haemoderivate Ges M.B.H. |
| Tisseel Kit VH 0.5Combination | Canada | 0.5 ML / VIAL + 0.5 ML / VIAL + 25 UNIT / VIAL + 55 MG / VIAL + 4.5 MG / VIAL + 60 MCG / VIAL + 250 UNIT / VIAL + 2 UNIT / VIAL + 65 MG / VIAL | Kit, Liquid, Powder For Solution | Cancelled | Baxter AG |
| Tisseel Kit VH 1.0Combination | Canada | 3000 KIU / 1 ML + 40 MCMOL / 1 ML + 50 UNIT / 1 ML + 110 MG / 1 ML + 9 MG / 1 ML + 120 MCG / 1 ML + 500 UNIT / 1 ML + 4 UNIT / 1 ML + 130 MG / 1 ML | Kit, Liquid, Powder For Solution | Cancelled | Baxter AG |
| Tisseel Kit VH 2.0Combination | Canada | 6000 KIU / 2 ML + 80 MCMOL / 2 ML + 100 UNIT / 2 ML + 220 MG / 2 ML + 18 MG / 2 ML + 240 MCG / 2 ML + 8 UNIT / 2 ML + 1000 UNIT / 2 ML + 260 MG / 2 ML | Kit, Liquid, Powder For Solution | Cancelled | Baxter AG |
| Tisseel Kit VH 5.0Combination | Canada | 15000 KIU / 5 ML + 200 MCMOL / 5 ML + 250 UNIT / 5 ML + 550 MG / 5 ML + 45 MG / 5 ML + 600 MCG / 5 ML + 2500 UNIT / 5 ML + 20 UNIT / 5 ML + 650 MG / 5 ML | Kit, Liquid, Powder For Solution | Cancelled | Baxter AG |



